Auto-associative heparin nanoassemblies: A biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 1, 2014, Pages 275-282

  Lembo, David ^a   Donalisio, Manuela ^a   Laine, Claire ^b   Cagno, Valeria ^a   Civra, Andrea ^a   Bianchini, Elsa P ^b   Zeghbib, Narimane ^b   Bouchemal, Kawthar ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Glycosaminoglycan; Heparin; HPV; HSV; Nanoassemblies; Cyclodextrin

Indexed keywords

ALPHA CYCLODEXTRIN DERIVATIVE; ALPHA-CYCLODEXTRIN; ANTICOAGULANT AGENT; ANTIVIRUS AGENT; HEPARIN; NANOPARTICLE; WATER;

ANIMAL; BIOMIMETICS; CELL SURVIVAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; CRYSTALLIZATION; DRUG EFFECTS; HEK293 CELL LINE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRODYNAMICS; NANOTECHNOLOGY; PIG; PROCEDURES; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; VERO CELL LINE;

ALPHA-CYCLODEXTRINS; ANIMALS; ANTICOAGULANTS; ANTIVIRAL AGENTS; BIOMIMETICS; CELL LINE, TUMOR; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CRYSTALLIZATION; HEK293 CELLS; HEPARIN; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMAN PAPILLOMAVIRUS 16; HUMANS; HYDRODYNAMICS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTECHNOLOGY; RESPIRATORY SYNCYTIAL VIRUSES; SWINE; VERO CELLS; WATER;

EID: 84934271741     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.05.007     Document Type: Article

References (37)

1. D. Spillmann Heparan sulfate: anchor for viral intruders? Biochimie 83 2001 811 817
2. J. Liu, and S.C. Thorp Cell surface heparan sulfate and its roles in assisting viral infections Med. Res. Rev. 22 2002 1 25
3. U. Lindahl, K. Lidholt, D. Spillmann, and L. Kjellen More to "heparin" than anticoagulation Thromb. Res. 75 1994 1 32
4. D.L. Rabenstein Heparin and heparan sulfate: structure and function Nat. Prod. Rep. 19 2002 312 331
5. S.A. Feldman, R.M. Hendry, and J.A. Beeler Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G J. Virol. 73 1999 6610 6617
6. D. WuDunn, and P.G. Spear Initial interaction of herpes simplex virus with cells is binding to heparan sulphate J. Virol. 63 1989 52 58
7. T. Giroglou, L. Florin, F. Schäfer, R.E. Streeck, and M. Sapp Human papilloma infection requires cell surface heparan sulfate J. Virol. 75 2001 1565 1570
8. M. Rusnati, E. Vicenzi, M. Donalisio, P. Oreste, S. Landolfo, and D. Lembo Sulfated K5 Escherichia coli polysaccharide derivatives: a novel class of candidate antiviral microbicides Pharmacol. Ther. 123 2009 310 322
9. V. Tiwari, E. Maus, I.M. Sigar, K.H. Ramsey, and D. Shukla Role of heparan sulfate in sexually transmitted infections Glycobiology 22 2012 1402 1412
10. A.J. Nahmias, and S. Kibrick Inhibitory effect of heparin on herpes simplex virus J. Bacteriol. 87 1964 1060 1066
11. J.G. Joyce, J-S. Tung, C.T. Przysiecji, J.C. Cook, E.D. Lehman, J.A. Sands, K.U. Jansen, and P.M. Keller The L1 major capside protein of human papillomavirus Type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes J. Biol. Chem. 274 1999 5810 5822
12. K.M. Johnson, R.C. Kines, J.N. Roberts, D.R. Lowy, J.T. Schiller, and P.M. Day Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus J. Virol. 83 2009 2067 2074
13. K. Bouchemal, Microparticles and Nanoparticles Made Up of Hydrophobized Polysaccharides and Alpha-Cyclodextrin, WO/2013/150193A1.
14. C.B. Buck, D.V. Pastrana, D.R. Lowy, and J.T. Schiller Efficient intracellular assembly of papillomaviral vectors J. Virol. 78 2004 751 757
15. M. Donalisio, M. Rusnati, V. Cagno, A. Civra, A. Bugatti, A. Giuliani, G. Pirri, M. Volante, M. Papotti, S. Landolfo, and D. Lembo Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide Antimicrob. Agents Chemother. 56 2012 5278 5288
16. B.S. Coulson, J.M. Tursi, W.J. McAdam, and R.F. Bishop Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3 Virology 154 1986 302 312
17. C.B. Buck, C.D. Thompson, Y.Y. Pang, D.R. Lowy, and J.T. Schiller Maturation of papillomavirus capsids J. Virol. 79 2005 2839 2846
18. E.P. Bianchini, J. Fazavana, V. Picard, and D. Borgel Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives Blood 117 2011 2054 2060
19. U. Lindahl, and L. Kjellén Heparin or heparan sulfate - what is the difference? Thromb. Haemostasis 66 1991 44 48
20. Z.H. Liu, Y.P. Jiao, F. Liu, and Z.Y. Zhang Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation J. Biomed. Mater. Res. 83A 2007 806 812
21. K. Park, K. Kim, I.C. Kwon, S.K. Kim, S. Lee, D.Y. Lee, and Y. Byun Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates Langmuir 20 2004 11726 11731
22. C. Sicard-Roselli, B. Perly, and G. Le Bas The respective benefits of X-ray crystallography and NMR for the structural determination of the inclusion complex between butyl-isothiocyanate and alpha-cyclodextrin J. Incl. Phenom. Macrocycl. Chem. 39 2001 333 337
23. M. Noltemeyer, and W. Saenger Structural chemistry of linear α-cyclodextrin-polyiodide complexes. X-ray crystal structures of (α-cyclodextrin)2·LiI3·I2·8H2O and (α-cyclodextrin)2·Cd0.5·I5·27H2O. Models for the blue amylose-iodine complex J. Am. Chem. Soc. 102 1980 2710 2722
24. S.S. Terdale, D.H. Dagade, and K.J. Patil Thermodynamic studies of drug-α-cyclodextrin interactions in water at 298.15 K: promazine hydrochloride/chlorpromazine hydrochloride + α-cyclodextrin + H2O systems J. Phys. Chem. B 111 2007 13645 13652
25. K. Eliadou, K. Yannakopoulou, A. Rontoyianni, and I.M. Mavridis NMR detection of simultaneous formation of [2]-and [3] pseudorotaxanes in aqueous solution between α-cyclodextrin and linear aliphatic α, ω-amino acids, an α, ω-diamine and an α, ω-diacid of similar length, and comparison with the solid-state structures J. Org. Chem. 64 1999 6217 6226
26. D. Gallois-Montbrun, G. Le Bas, S.A. Mason, T. Prange, and S. Lesieur A highly hydrated-cyclodextrin/1-undecanol inclusion complex: crystal structure and hydrogen-bond network from high-resolution neutron diffraction at 20 K Acta. Crystallogr. B 69 2013 214 227
27. G. Castronuovo, V. Elia, F. Velleca, and G. Viscardi Thermodynamics of the interaction of α-cyclodextrin with α, ω-dicarboxylic acids in aqueous solutions. A calorimetric study at 25 °C Thermochim. Acta 292 1997 13 37
28. K. Yannakopoulou, J.A. Ripmeester, and I.M. Mavridis Release of the Prays oleae pheromone as a consequence of supramolecular structure: study of the β-cyclodextrin-(Z)-tetradec-7-en-1-al complex by X-ray crystallography and NMR spectroscopy in the solid state and in solution J. Chem. Soc. Perkin Trans. 2 2 2002 1639 1644
29. R.D. Hutton, D.L. Ewert, and G.R. French Differentiation of types 1 and 2 of herpes simplex virus by plaque inhibition with sulfated polyanions Proc. Soc. Exp. Biol. Med. 142 1973 27 29
30. S. López, and C.F. Arias Multistep entry of rotavirus into cells: a Versaillesque dance Trends. Microbiol. 12 2004 271 278
31. F. Castelli, G. Giammona, A. Raudino, and G. Puglisi Macromolecular prodrugs interaction with mixed lipid membrane. A calorimetric study of naproxen linked to polyaspartamide interacting with phosphatidylcholine and phosphatidylcholine-phosphatidic acid vesicles Int. J. Pharm. 70 1991 43 52
32. J.A. Champion, Y.K. Katare, and S. Mitragotri Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers J. Control. Rel. 121 2007 3 9
33. B.D. Chithrani, A.A. Ghazani, and W.C.W. Chan Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano. Lett. 6 2006 662 668
34. M. Ornatska, S. Peleshanko, K.L. Genson, B. Rybak, K.N. Bergman, and V.V. Tsukruk Assembling of amphiphilic highly branched molecules in supramolecular nanofibers J. Am. Chem. Soc. 126 2004 9675 9684
35. O. Cauchois, F. Segura-Sanchez, and G. Ponchel Molecular weight controls the elongation of oblate-shaped degradable poly (γ-benzyl-l-glutamate) nanoparticles Int. J. Pharm. 452 2013 292 299
36. B.C. Herold, S.I. Gerber, T. Polonsky, B.J. Belval, P.N. Shaklee, and K. Holme Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding Virology 206 1995 1108 1116
37. S. Alban, A. Schauerte, and G. Franz Anticoagulant sulfated polysaccharides Part I Synthesis and structure-activity relationships of new pullulan sulfates Carbohyd. Polym. 47 2002 267 276